PL373219A1 - Infertility treatment with exemestane - Google Patents

Infertility treatment with exemestane

Info

Publication number
PL373219A1
PL373219A1 PL03373219A PL37321903A PL373219A1 PL 373219 A1 PL373219 A1 PL 373219A1 PL 03373219 A PL03373219 A PL 03373219A PL 37321903 A PL37321903 A PL 37321903A PL 373219 A1 PL373219 A1 PL 373219A1
Authority
PL
Poland
Prior art keywords
exemestane
infertility treatment
infertility
treatment
Prior art date
Application number
PL03373219A
Other languages
Polish (pl)
Inventor
Charles P. Wajszczuk
Gans Hendrik J. Dekoning
Original Assignee
Pharmacia & Upjohn Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Llc filed Critical Pharmacia & Upjohn Company Llc
Publication of PL373219A1 publication Critical patent/PL373219A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL03373219A 2002-07-02 2003-07-02 Infertility treatment with exemestane PL373219A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39332002P 2002-07-02 2002-07-02

Publications (1)

Publication Number Publication Date
PL373219A1 true PL373219A1 (en) 2005-08-22

Family

ID=30115565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03373219A PL373219A1 (en) 2002-07-02 2003-07-02 Infertility treatment with exemestane

Country Status (12)

Country Link
EP (1) EP1531829A2 (en)
JP (1) JP2005536490A (en)
KR (1) KR20050077045A (en)
CN (1) CN1665516A (en)
AU (1) AU2003247404A1 (en)
BR (1) BR0312393A (en)
CA (1) CA2491372A1 (en)
IL (1) IL165813A0 (en)
MX (1) MXPA05000251A (en)
PL (1) PL373219A1 (en)
WO (1) WO2004004634A2 (en)
ZA (1) ZA200410135B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102432156B1 (en) * 2020-05-18 2022-08-11 제주대학교 산학협력단 Composition comprising chemical material for inhibiting gonadal maturation in fishes and method for inhibiting gonadal maturation in fishes using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040025916A (en) * 2001-04-17 2004-03-26 아레스 트레이딩 에스.에이. Single dose aromatase inhibitor for treating infertility
ES2283541T3 (en) * 2001-04-17 2007-11-01 Ares Trading S.A. INHIBITION OF AROMATASE TO IMPROVE THE IMPLEMENTATION INDEX.

Also Published As

Publication number Publication date
MXPA05000251A (en) 2005-07-15
EP1531829A2 (en) 2005-05-25
CA2491372A1 (en) 2004-01-15
BR0312393A (en) 2005-04-12
IL165813A0 (en) 2006-01-15
KR20050077045A (en) 2005-07-29
WO2004004634A2 (en) 2004-01-15
CN1665516A (en) 2005-09-07
ZA200410135B (en) 2006-07-26
WO2004004634A3 (en) 2004-04-08
AU2003247404A1 (en) 2004-01-23
JP2005536490A (en) 2005-12-02

Similar Documents

Publication Publication Date Title
GB0213599D0 (en) Process
GB0210143D0 (en) Process
GB0211789D0 (en) Process
GB0213485D0 (en) Process
GB0205016D0 (en) Process
HK1060840A1 (en) Massager
GB0201505D0 (en) Process
GB0210455D0 (en) Treatment system
GB0210225D0 (en) Process
GB0202564D0 (en) Process
GB0205014D0 (en) Process
GB0221157D0 (en) Novel treatment
GB0201378D0 (en) Process
IL165813A0 (en) Infertility treatment with exemestane
GB0202563D0 (en) Process
GB0219104D0 (en) Trouser-type massager
GB0212974D0 (en) Process
GB0219292D0 (en) Process
GB0210183D0 (en) Process
GB0218014D0 (en) Process
GB0213461D0 (en) Baths
GB0203665D0 (en) Process
GB0212821D0 (en) Eyewash
GB0210185D0 (en) Process
GB0213493D0 (en) Treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)